Suppr超能文献

口服舒马曲坦后发生致命性心律失常。

Fatal cardiac arrhythmia after oral sumatriptan.

作者信息

Laine K, Raasakka T, Mäntynen J, Saukko P

机构信息

Department of Pharmacology and Clinical Pharmacology, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.

出版信息

Headache. 1999 Jul-Aug;39(7):511-2. doi: 10.1046/j.1526-4610.1999.3907511.x.

Abstract

Typically, 3% to 5% of patients experience sensations of heaviness, pressure, and tightness in the chest after administration of sumatriptan, but there is little ECG evidence of ischemia. The serious cardiovascular incidents after consuming sumatriptan have been associated mostly with the subcutaneous dosage form of this drug and with patients with underlying cardiovascular risk factors. We report a case of fatal cardiac arrhythmia in an otherwise perfectly healthy patient with migraine after consuming a single 100-mg dose of oral sumatriptan.

摘要

通常,3%至5%的患者在服用舒马曲坦后会出现胸部沉重、压迫和紧绷感,但几乎没有心电图显示缺血的证据。服用舒马曲坦后的严重心血管事件大多与该药物的皮下剂型以及有潜在心血管危险因素的患者有关。我们报告一例原本完全健康的偏头痛患者,在服用单次100毫克口服舒马曲坦后发生致命性心律失常的病例。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验